1 [1]] Testoni, M., Chung, E.Y., Priebe, V. and Bertoni, F. (2015) The transcription factor ETS1 in lymphomas: friend or foe? Leuk Lymphoma 56, 1975-1980, 10.3109/10428194.2014.981670
2 [1]] Nazir, S.U., Kumar, R., Singh, A., Khan, A., Tanwar, P. and Tripathi, R. et al. (2019) Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor. Gene 711, 143952, 10.1016/j.gene.2019.143952
3 [1]] Mao, S., Zhang, W., Yang, F., Guo, Y., Wang, H. and Wu, Y. et al. (2021) Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA. J Exp Clin Cancer Res 40, 336, 10.1186/s13046-021-02138-8
4 [1]] Liu, O., Wang, C., Wang, S., Hu, Y., Gou, R. and Dong, H. et al. (2021) Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer. J. Cancer 12, 6835-6850, 10.7150/jca.64031
5 [1]] Kori, M., Gov, E. and Arga, K.Y. (2019) Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis. Omics 23, 261-273, 10.1089/omi.2019.0025
6 [1]] Garrett-Sinha, L.A. (2013) Review of Ets1 structure, function, and roles in immunity. Cell. Mol. Life Sci. 70, 3375-3390, 10.1007/s00018-012-1243-7
7 [1]] Abbott, M. and Ustoyev, Y. (2019) Cancer and the Immune System: The History and Background of Immunotherapy. Semin Oncol Nurs 35, 150923, 10.1016/j.soncn.2019.08.002
8 [1]] Prieto, L.I. and Baker, D.J. (2019) Cellular Senescence and the Immune System in Cancer. Gerontology 65, 505-512, 10.1159/000500683
9 [1]] Arneth, B. (2019) Tumor Microenvironment. Medicina (Kaunas) 56, 10.3390/medicina56010015
10 [1]] Kaymak, I., Williams, K.S., Cantor, J.R. and Jones, R.G. (2021) Immunometabolic Interplay in the Tumor Microenvironment. Cancer Cell 39, 28-37, 10.1016/j.ccell.2020.09.004
11 [1]] Tan, S., Li, D. and Zhu, X. (2020) Cancer immunotherapy: Pros, cons and beyond. Biomed. Pharmacother. 124, 109821, 10.1016/j.biopha.2020.109821
12 [1]] Wang Zhining,Jensen Mark A,Zenklusen Jean Claude. A Practical Guide to The Cancer Genome Atlas (TCGA).[J]. Methods in molecular biology (Clifton, N.J.),2016,1418:
13 [1]] Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O. and Aksoy, B.A. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404, 10.1158/2159-8290.CD-12-0095
14 [1]] Greillier, L., Tomasini, P. and Barlesi, F. (2018) The clinical utility of tumor mutational burden in non-small cell lung cancer. Transl Lung Cancer Res 7, 639-646, 10.21037/tlcr.2018.10.08
15 [1]] Hause, R.J., Pritchard, C.C., Shendure, J. and Salipante, S.J. (2016) Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342-1350, 10.1038/nm.4191
16 [1]] Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L. and Gillette, M.A. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550, 10.1073/pnas.0506580102
17 [1]] Franz, M., Rodriguez, H., Lopes, C., Zuberi, K., Montojo, J. and Bader, G.D. et al. (2018) GeneMANIA update 2018. Nucleic Acids Res. 46, W60-W64, 10.1093/nar/gky311
18 [1]] Wasylyk, C., Schlumberger, S.E., Criqui-Filipe, P. and Wasylyk, B. (2002) Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol. Cell. Biol. 22, 2687-2702, 10.1128/MCB.22.8.2687-2702.2002
19 [1]] Yordy, J.S., Li, R., Sementchenko, V.I., Pei, H., Muise-Helmericks, R.C. and Watson, D.K. (2004) SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. Oncogene 23, 6654-6665, 10.1038/sj.onc.1207891
20 [1]] Yordy, J.S., Moussa, O., Pei, H., Chaussabel, D., Li, R. and Watson, D.K. (2005) SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene 24, 916-931, 10.1038/sj.onc.1208245
21 [1]] Mei, D., Qi, Y., Xia, Y., Ma, J., Hu, H. and Ai, J. et al. (2021) Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer. World J. Surg. Oncol. 19, 311, 10.1186/s12957-021-02417-w
22 [1]] Chen, Y., Peng, C., Chen, J., Chen, D., Yang, B. and He, B. et al. (2019) WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol. Cancer 18, 127, 10.1186/s12943-019-1053-8
23 [1]] Gu, C., Cai, J., Xu, Z., Zhou, S., Ye, L. and Yan, Q. et al. (2019) MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/beta-catenin signaling. Cell Death Dis. 10, 739, 10.1038/s41419-019-1962-x
24 [1]] Liu, J., Li, D., Zhang, X., Li, Y. and Ou, J. (2020) Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis. Onco Targets Ther 13, 11957-11973, 10.2147/OTT.S276559
25 [1]] Ding, L., Wang, L., Li, Z., Jiang, X., Xu, Y. and Han, N. (2020) The positive feedback loop of RHPN1-AS1/miR-1299/ETS1 accelerates the deterioration of gastric cancer. Biomed. Pharmacother. 124, 109848, 10.1016/j.biopha.2020.109848
26 [1]] Rodgers, J.J., Mcclure, R., Epis, M.R., Cohen, R.J., Leedman, P.J. and Harvey, J.M. et al. (2019) ETS1 induces transforming growth factor beta signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. J. Cell. Biochem. 120, 848-860, 10.1002/jcb.27446
27 [1]] Mei, D., Qi, Y., Xia, Y., Ma, J., Hu, H. and Ai, J. et al. (2021) Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer. World J. Surg. Oncol. 19, 311, 10.1186/s12957-021-02417-w
28 [1]] He, L., Liu, L., Li, T., Zhuang, D., Dai, J. and Wang, B. et al. (2021) Exploring the Imbalance of Periodontitis Immune System From the Cellular to Molecular Level. Front Genet 12, 653209, 10.3389/fgene.2021.653209
29 [1]] Wu, H. and Ballantyne, C.M. (2017) Skeletal muscle inflammation and insulin resistance in obesity. J. Clin. Invest. 127, 43-54, 10.1172/JCI88880
30 [1]] Taveirne, S., Wahlen, S., Van Loocke, W., Kiekens, L., Persyn, E. and Van Ammel, E. et al. (2020) The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation. Blood 136, 288-298, 10.1182/blood.2020005204
31 [1]] Dittmer, J. (2015) The role of the transcription factor Ets1 in carcinoma. Semin. Cancer Biol. 35, 20-38, 10.1016/j.semcancer.2015.09.010
32 [1]] Chan, T.A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S.A. and Stenzinger, A. et al. (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann. Oncol. 30, 44-56, 10.1093/annonc/mdy495
33 [1]] Yamamoto, H. and Imai, K. (2019) An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine. Semin. Oncol. 46, 261-270, 10.1053/j.seminoncol.2019.08.003
34 [1]] Berg, V., Rusch, M., Vartak, N., Jungst, C., Schauss, A. and Waldmann, H. et al. (2015) miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL. Blood 125, 2948-2957, 10.1182/blood-2014-07-586511
35 [1]] Izquierdo, J.M. (2010) Heterogeneous ribonucleoprotein C displays a repressor activity mediated by T-cell intracellular antigen-1-related/like protein to modulate Fas exon 6 splicing through a mechanism involving Hu antigen R. Nucleic Acids Res. 38, 8001-8014, 10.1093/nar/gkq698